giovannelli-associati-logogiovannelli-associati-logo-stickygalaw-giovannelli-e-associati-logo-mobile-centro-130×35giovannelli-associati-logo
  • HOME
  • OUR FIRM
    • About us
    • International strategy
  • TEAM
    • Partners
    • Of Counsel
    • Associates
  • PRACTICE AREAS
    • Mergers and Acquisitions – Private Equity
    • Finance & Restructuring
    • Capital Markets
    • Corporate and Commercial matters
    • Intellectual Property
    • Labour Law
    • Litigation and Arbitration
    • Privacy
    • Tax
  • MEDIA
  • WORK WITH US
  • CONTACTS
English
  • Italian
✕
HOT LABOUR TOPICS – The credit of an employee can (also) be split
11/09/2019
Giovannelli e Associati advised Intervieweb on the sale of the 100% of the shares to Zucchetti
16/09/2019
Mostra tutto

Giovannelli e Associati advised Genenta Science on a new round of financing of about Euro 13 million

Pubblicato da Giovannelli e Associati il 16/09/2019

Giovannelli e Associati advised Genenta Science on a new round of financing of about Euro 13 million.

Genenta Science is a biotechnology company operating in the development of hematopoietic stem cell gene therapies for cancer which was founded in 2014 by Pierluigi Paracchi, by Ospedale San Raffaele (OSR) and by two physician-scientists, prof. Luigi Naldini and Bernhard Gentner.

This is the third round of the company which has reached a total amount of Euro 30,2 million since its incorporation.

The team of Giovannelli e Associati was led by partners Alessandra Pieretti and Gianvittorio Giroletti and comprised associates Lilia Montella e Alberto Corolla.

Read More:

Genenta Science – Globallegalchronicle – 11.09.2019
Genenta Science – Legalcommunity – 11.09.2019
Genenta Science – Top Legal – 11.09.2019
Condividi

Media correlati

10/08/2022

Giovannelli e Associati advised Neopharmed Gentili on the acquisition of the entire share capital of Valeas


Leggi tutto
29/07/2022

Giovannelli e Associati with Neva SGR on the investment round of Casavo


Leggi tutto
20/07/2022

Giovannelli e Associati with Blacksheep Madtech Fund on the investment round of iGenius


Leggi tutto

Cerca news e media

✕

Latest News&Media

  • Giovannelli e Associati advised Neopharmed Gentili on the acquisition of the entire share capital of Valeas
    10/08/2022
  • Giovannelli e Associati with Neva SGR on the investment round of Casavo
    29/07/2022
  • Giovannelli e Associati with Blacksheep Madtech Fund on the investment round of iGenius
    20/07/2022

Categories

  • Articles
  • Giovannelli e Associati @en
  • HOT TOPICS: LABOUR
  • HOT TOPICS: TAX
  • News
  • Press Release

Pratice Areas

  • Mergers and Acquisitions – Private Equity
  • Finance & Restructuring
  • Capital Markets
  • Corporate and Commercial matters
  • Intellectual Property
  • Labour Law
  • Litigation and Arbitration
  • Privacy
  • Tax
© Copyright 2021 Giovannelli e Associati | Via dei Bossi, 4 20121 Milano, Italia | P.IVA 08347040969 | Note Legali | Privacy Policy | Credits